Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transcutaneous Electrical Acustimulation (TEA) for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D): A Multicenter, Randomized, Sham-Controlled Trial

NCT07425145 is registered in ClinicalTrials.gov with First People's Hospital of Foshan as lead sponsor.

NCT NCT07425145
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07425145 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transcutaneous Electrical Acustimulation (TEA) for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D): A Multicenter, Randomized, Sham-Controlled Trial
Lead sponsor
First People's Hospital of Foshan
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 1, 2026
Completion date
February 28, 2028
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ibs, diarrhea predominant